ClassID:

116178

C12Y301/01007 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Carboxylic ester hydrolases (3.1.1) Acetylcholinesterase (3.1.1.7)

Recent Application in this class:
#1
20260117275
2026-04-30

METHODS FOR QUANTITATING VIRAL CAPSIDS

#2
20240207373
2024-06-27

CYCLIC PEPTIDES FROM THE C-TERMINUS OF ACETYLCHOLINESTERASE FOR TREATMENT OF SKIN DISORDERS AND FOR COSMETICAL USE

#3
20240182878
2024-06-06

MODIFIED FILAMENTOUS FUNGUS AND METHOD FOR PRODUCING PROTEIN USING SAME

#4
20240058424
2024-02-22

NBP-14 FOR TREATING ALZHEIMER'S ASSOCIATED WITH DOWN'S SYNDROME

#5
20230026578
2023-01-26

Recombinant protein produced from cholinesterase gene derived from and the composition comprising the same for treating or preventing a neurological disease

#6
20220354966
2022-11-10

BIOACTIVE NANOPARTICLE COMPOSITIONS AND METHODS FOR MAKING SAME

#7
20210388331
2021-12-16

Neurodegenerative disorders

#8
20200369716
2020-11-26

SOLID-PHASE SYNTHESIS OF PROTEIN-POLYMER CONJUGATES ON IMMOBILIZATION SUPPORTS

#9
20200147183
2020-05-14

Cyclic acetylcholinesterase C-terminal peptide in the treatment or prevention of cancer or metastasis

#10
20200058367
2020-02-20

STABLE PROTEINS AND METHODS FOR DESIGNING SAME

#11
20190382749
2019-12-19

Polymer engineered regenerating bioscavengers

#12
20190382748
2019-12-19

Polymer engineered regenerating bioscavengers

#13
20190359956
2019-11-28

PHOSPHOTRIESTERASES FOR TREATING OR PREVENTING ORGANOPHOSPHATE EXPOSURE ASSOCIATED DAMAGE

#14
20190292576
2019-09-26

Point-of-care in-vitro diagnostic device for the amperometric detection of cholinesterase activity in whole blood for indication of exposure to cholinesterase inhibiting substances

#15
20190209705
2019-07-11

Bioactive nanoparticles and methods for making same

#16
20190100735
2019-04-04

Neurodegenerative disorders

#17
20190025289
2019-01-24

Cancer

#18
20180371437
2018-12-27

System and method for creating crystals of insect acetylcholinesterase

#19
20170368151
2017-12-28

Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis

#20
20170335415
2017-11-23

Compounds for reactivation of acetylcholinesterase and related compositions methods and systems

#21
20170266265
2017-09-21

Neurodegenerative disorders

#22
20170032079
2017-02-02

Stable proteins and methods for designing same

#23
20160377617
2016-12-29

Detection of the degree of exposure to chemical warfare nerve agents and organophosphate pesticides with lateral flow assays

#24
20160369250
2016-12-22

Neurodegenerative disorders

#25
20160355823
2016-12-08

Control of Varroa mite infestation

#26
20160289657
2016-10-06

Acetylcholinesterase-Fc domain fusion protein

#27
20160244741
2016-08-25

Polymer engineered regenerating bioscavengers

#28
20150368691
2015-12-24

One-step rapid assay for the detection of inhibitors of enzymes

#29
20150216993
2015-08-06

MULTIFUNCTIONAL SMALL MOLECULES

#30
20140328907
2014-11-06

Entrapment of bioactives in sol-gel alumina materials

#31
20130156749
2013-06-20

Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger

#32
20130102763
2013-04-25

Method of thermostabilization of a protein and/or stabilization towards organic solvents

#33
20120207738
2012-08-16

Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger

#34
20120196920
2012-08-02

ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES

#35
20110124708
2011-05-26

RNAI-MEDIATED INHIBITION OF OCULAR HYPERTENSION TARGETS

#36
20110064716
2011-03-17

MATERIALS AND METHODS FOR TREATING OR PREVENTING ORGANOPHOSPHATE EXPOSURE ASSOCIATED DAMAGE

#37
20110039791
2011-02-17

ACETYLCHOLINESTERASE (ACHE)-DERIVED PEPTIDE AS AN INDUCER OF GRANULOCYTOPOIESIS, USES AND METHODS THEREOF

#38
20090326044
2009-12-31

RNAi-Mediated Inhibition of Ocular Targets

#39
20090281165
2009-11-12

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

#40
20090275634
2009-11-05

ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES

#41
20090263370
2009-10-22

METHODS FOR TREATING TACHYKININ-MEDIATED DISEASES WITH CHOLINESTERASE

#42
20090068165
2009-03-12

Uniformly conjugated serine hydrolases

#43
20080256649
2008-10-16

Acetylcholinesterase gene responsible for insecticide resistance and applications thereof

#44
20070224181
2007-09-27

Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof

#45
20060178333
2006-08-10

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

#46
20060172965
2006-08-03

RNAi-mediated inhibition of ocular targets

#47
20060172963
2006-08-03

RNAi-mediated inhibition of ocular hypertension targets

#48
20060104966
2006-05-18

Transglutaminase linkage of agents to tissue

#49
20060099200
2006-05-11

Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger

#50
17511033
2024-02-27

Mass spectrometry ionization based-assay for the detection of enzyme activity and/or presence

#51
15976120
2021-11-02

Mass spectrometry ionization based-assay for the detection of enzyme activity and/or presence

#52
15840412
2019-07-30

Mutant OPAA enzyme with increased catalytic efficiency on GP